Filing Flows › Innospec (IOSP) › Q2 2026 › vs Q1 2026
Innospec (IOSP) Q2 2026 vs Q1 2026 (quarter over quarter)
Innospec's revenue rose $38.2M (+8%) from $453M in Q1 2026 to $491M in Q2 2026. Gross margin 28.1% against 27.3% (+0.9 pts).
Innospec, Q2 2026: revenue $491M (+12% year over year), operating margin 8.1%, net earnings $31.2M, operating cash flow $7.2M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 28.1% | 27.3% | +0.9 pts |
| Operating margin | 8.1% | 8.1% | +0.0 pts |
| Net margin | 6.3% | 6.8% | -0.4 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $491M | $453M | $38.2M | +8% |
| Gross profit | $138M | $124M | $14.8M | +12% |
| Cost of revenue | $353M | $330M | $23.4M | +7% |
| Other income, net | $1.9M | $3.4M | −$1.5M | -44% |
| Operating profit | $39.7M | $36.5M | $3.2M | +9% |
| Operating expenses | $98.6M | $87.0M | $11.6M | +13% |
| Pre-tax earnings | $41.6M | $39.9M | $1.7M | +4% |
| Net earnings | $31.2M | $30.8M | $400K | +1% |
| Income tax | $10.4M | $9.1M | $1.3M | +14% |
| Operating cash sources | $43.4M | $42.3M | $1.1M | +3% |
| Depreciation & amortization | $10.0M | $9.9M | $100K | +1% |
| Share-based compensation | $2.2M | $1.6M | $600K | +38% |
| Working capital & other | $36.2M | $24.7M | $11.5M | +47% |
| Operating cash flow | $7.2M | $17.6M | −$10.4M | -59% |
| Capital expenditures | $17.7M | $8.9M | $8.8M | +99% |
| Negative free cash flow (OCF − capex) | $10.5M | −$8.7M | $19.2M | — |
Questions
How much did Innospec's revenue grow quarter over quarter in Q2 2026?
Innospec's revenue rose $38.2M (+8%) from $453M in Q1 2026 to $491M in Q2 2026. Gross margin 28.1% against 27.3% (+0.9 pts).